Population pharmacokinetic modelling of intravenous immunoglobulin in patients with predominantly antibody deficiencies-Reference-Cited by-同舟云学术

Population pharmacokinetic modelling of intravenous immunoglobulin in patients with predominantly antibody deficiencies

Published:2021-01-11 Issue:7 Volume:87 Page:2956-2966
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Lee Jian Lynn¹²^ORCID,Mohd Saffian Shamin¹^ORCID,Makmor‐Bakry Mohd¹^ORCID,Islahudin Farida¹^ORCID,Alias Hamidah³^ORCID,Noh Lokman Mohd⁴,Ismail Intan Hakimah⁵^ORCID,Mohamed Shah Noraida¹^ORCID

Affiliation:

1. Centre for Quality Management of Medicines, Faculty of Pharmacy Universiti Kebangsaan Malaysia Kuala Lumpur Malaysia

2. Department of Pharmacy Tengku Ampuan Rahimah Hospital, Ministry of Health Malaysia Klang Selangor Darul Ehsan Malaysia

3. Department of Pediatrics, UKM Medical Centre, Faculty of Medicine Universiti Kebangsaan Malaysia Cheras Kuala Lumpur Malaysia

4. Department of Pediatrics Tunku Azizah Women & Children Hospital, Ministry of Health Malaysia Kuala Lumpur Malaysia

5. Department of Pediatrics, Faculty of Medicine and Health Sciences Universiti Putra Malaysia Serdang Selangor Darul Ehsan Malaysia

Funder

Ministry of Higher Education, Malaysia

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14712

Reference50 articles.

1. Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee

2. The Prevalances and Patient Characteristics of Primary Immunodeficiency Diseases in Turkey—Two Centers Study

3. Delayed Diagnosis and Complications of Predominantly Antibody Deficiencies in a Cohort of Australian Adults

4. Clinical‐epidemiological pattern of primary immunodeficiencies in Malaysia 1987‐2006: A 20 year experience in four Malaysian hospitals;Noh LM;Med J Malaysia,2013

5. Primary Immunodeficiency Diseases in Australia and New Zealand

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated population pharmacokinetics of immunoglobulin G following intravenous or subcutaneous administration of various immunoglobulin products in patients with primary immunodeficiencies;International Immunopharmacology;2022-12

2. Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain–Barré Syndrome;Clinical Pharmacokinetics;2022-07-04

3. A systematic review of population pharmacokinetic analyses of polyclonal immunoglobulin G therapy;International Immunopharmacology;2021-08